16
total announcements
524470.BO · 15 min delayed
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd has announced that its promoters have voluntarily waived their entitlement to receive the final dividend proposed for the financial year ended 31st March 2026.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd has announced the closure of its trading window from 1st October 2026 until 48 hours after the declaration of its unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2026.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd submits copy of newspaper clippings of Notice of 38th Annual General Meeting (AGM), Remote E-Voting, Book Closure and other details.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd submits press clipping related to un-audited standalone and consolidated financial results for the quarter ended June 30, 2026.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd announced changes in its management, including the resignation of three directors and the appointment of two new directors. The resigning directors are Shri Kedarmal Shankarlal Bankda, Shri Vijay Shankarlal Bankda, and Shri Rahul Vijay Bankda. The new directors appointed are Smt. Rinki Ankit Bankda and Shri Ankur Vijay Bankda. The changes are effective from August 11, 2026, and August 12, 2026, respectively.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd has announced the provision of Remote E-Voting facilities for its 38th Annual General Meeting to be held on 30th September, 2026.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd has appointed M/s M. Goyal & Co. Cost Accountants as the Cost Auditor and M/s Bansal & Agrawal as the Internal Auditor for the financial year 2026-27.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 12,465.95 lakhs and profit before exceptional items and tax at Rs. 3,190.88 lakhs.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd has announced the fixing of record date for determining the entitlement of members for payment of dividend at the rate of 10% for the financial year 2025-26, subject to approval by the members at their ensuing 38th Annual General Meeting.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd's board meeting outcome announced, with approval of unaudited financial results, limited review report, and other business matters. Resignations of directors and appointments of new directors and CFO. Final dividend recommendation and record date set.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd has announced the resignation of its Managing Director, Mr. Vijay Shankarlal Bankda, effective August 11, 2026, citing leadership transition and succession planning.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd announces the resignation of its Managing Director, Mr. Vijay Shankarlal Bankda, effective August 11, 2026, as per Regulation 30 of SEBI (LODR) Regulations, 2015.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd has announced the resignation of its Chief Financial Officer (CFO), Mr. Rahul Vijay Bankda, effective August 11, 2026.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd has announced the resignation of Mr. Kedarmal Shankarlal Bankda as Whole-Time Director, effective August 11, 2026.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd has scheduled its 2/2026-27 Board Meeting on August 11th to consider dividend, financial results, and other matters.
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 11/08/2026 to consider and approve standalone and consolidated unaudited financial results for the quarter ended 30th June, 2026, and to consider recommending the final dividend for the financial year ended 31st March, 2026.